vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($173.1M vs $123.8M, roughly 1.4× NATURES SUNSHINE PRODUCTS INC). PATHWARD FINANCIAL, INC. runs the higher net margin — 20.3% vs 3.3%, a 17.0% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.

CASH vs NATR — Head-to-Head

Bigger by revenue
CASH
CASH
1.4× larger
CASH
$173.1M
$123.8M
NATR
Growing faster (revenue YoY)
NATR
NATR
+5.0% gap
NATR
4.7%
-0.2%
CASH
Higher net margin
CASH
CASH
17.0% more per $
CASH
20.3%
3.3%
NATR
More free cash flow
CASH
CASH
$96.5M more FCF
CASH
$104.1M
$7.6M
NATR
Faster 2-yr revenue CAGR
NATR
NATR
Annualised
NATR
5.6%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CASH
CASH
NATR
NATR
Revenue
$173.1M
$123.8M
Net Profit
$35.2M
$4.1M
Gross Margin
72.5%
Operating Margin
24.6%
4.3%
Net Margin
20.3%
3.3%
Revenue YoY
-0.2%
4.7%
Net Profit YoY
11.9%
1379.4%
EPS (diluted)
$1.57
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
NATR
NATR
Q4 25
$173.1M
$123.8M
Q3 25
$186.7M
$128.3M
Q2 25
$195.8M
$114.8M
Q1 25
$274.8M
$113.2M
Q4 24
$182.6M
$118.2M
Q3 24
$179.5M
$114.6M
Q2 24
$188.6M
$110.6M
Q1 24
$257.6M
$111.0M
Net Profit
CASH
CASH
NATR
NATR
Q4 25
$35.2M
$4.1M
Q3 25
$38.8M
$5.3M
Q2 25
$42.1M
$5.3M
Q1 25
$75.0M
$4.7M
Q4 24
$30.0M
$-321.0K
Q3 24
$33.5M
$4.3M
Q2 24
$44.9M
$1.3M
Q1 24
$69.9M
$2.3M
Gross Margin
CASH
CASH
NATR
NATR
Q4 25
72.5%
Q3 25
73.3%
Q2 25
71.7%
Q1 25
72.1%
Q4 24
72.0%
Q3 24
71.3%
Q2 24
71.4%
Q1 24
71.2%
Operating Margin
CASH
CASH
NATR
NATR
Q4 25
24.6%
4.3%
Q3 25
25.9%
7.0%
Q2 25
24.1%
3.7%
Q1 25
33.2%
5.4%
Q4 24
19.8%
3.8%
Q3 24
20.9%
4.6%
Q2 24
27.1%
5.1%
Q1 24
33.8%
4.2%
Net Margin
CASH
CASH
NATR
NATR
Q4 25
20.3%
3.3%
Q3 25
20.8%
4.2%
Q2 25
21.5%
4.6%
Q1 25
27.3%
4.2%
Q4 24
16.4%
-0.3%
Q3 24
18.7%
3.8%
Q2 24
23.8%
1.2%
Q1 24
27.1%
2.1%
EPS (diluted)
CASH
CASH
NATR
NATR
Q4 25
$1.57
$0.23
Q3 25
$1.69
$0.30
Q2 25
$1.81
$0.28
Q1 25
$3.14
$0.25
Q4 24
$1.23
$-0.02
Q3 24
$1.34
$0.23
Q2 24
$1.78
$0.07
Q1 24
$2.74
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
NATR
NATR
Cash + ST InvestmentsLiquidity on hand
$331.2M
$93.9M
Total DebtLower is stronger
$33.5M
Stockholders' EquityBook value
$854.5M
$161.6M
Total Assets
$7.6B
$261.1M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
NATR
NATR
Q4 25
$331.2M
$93.9M
Q3 25
$120.6M
$95.6M
Q2 25
$258.3M
$81.3M
Q1 25
$254.2M
$86.5M
Q4 24
$597.4M
$84.7M
Q3 24
$158.3M
$78.7M
Q2 24
$298.9M
$68.7M
Q1 24
$347.9M
$77.8M
Total Debt
CASH
CASH
NATR
NATR
Q4 25
$33.5M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
Q2 24
$33.3M
Q1 24
$33.4M
$2.1M
Stockholders' Equity
CASH
CASH
NATR
NATR
Q4 25
$854.5M
$161.6M
Q3 25
$858.0M
$166.7M
Q2 25
$819.0M
$163.7M
Q1 25
$814.7M
$167.1M
Q4 24
$758.3M
$161.0M
Q3 24
$822.5M
$162.6M
Q2 24
$748.4M
$156.4M
Q1 24
$719.5M
$159.7M
Total Assets
CASH
CASH
NATR
NATR
Q4 25
$7.6B
$261.1M
Q3 25
$7.2B
$264.8M
Q2 25
$7.2B
$254.9M
Q1 25
$7.0B
$252.7M
Q4 24
$7.6B
$240.9M
Q3 24
$7.5B
$245.3M
Q2 24
$7.5B
$235.8M
Q1 24
$7.4B
$247.3M
Debt / Equity
CASH
CASH
NATR
NATR
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×
Q1 24
0.05×
0.01×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
NATR
NATR
Operating Cash FlowLast quarter
$108.3M
$9.9M
Free Cash FlowOCF − Capex
$104.1M
$7.6M
FCF MarginFCF / Revenue
60.1%
6.1%
Capex IntensityCapex / Revenue
2.4%
1.9%
Cash ConversionOCF / Net Profit
3.08×
2.41×
TTM Free Cash FlowTrailing 4 quarters
$616.8M
$28.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
NATR
NATR
Q4 25
$108.3M
$9.9M
Q3 25
$303.7M
$18.5M
Q2 25
$30.4M
$4.3M
Q1 25
$188.3M
$2.6M
Q4 24
$-71.7M
$12.2M
Q3 24
$143.1M
$9.6M
Q2 24
$113.2M
$1.3M
Q1 24
$203.0M
$2.2M
Free Cash Flow
CASH
CASH
NATR
NATR
Q4 25
$104.1M
$7.6M
Q3 25
$300.3M
$16.8M
Q2 25
$27.7M
$3.0M
Q1 25
$184.7M
$1.5M
Q4 24
$-73.8M
$10.0M
Q3 24
$138.8M
$7.9M
Q2 24
$111.0M
$-2.0M
Q1 24
$201.3M
$-1.5M
FCF Margin
CASH
CASH
NATR
NATR
Q4 25
60.1%
6.1%
Q3 25
160.9%
13.1%
Q2 25
14.1%
2.6%
Q1 25
67.2%
1.3%
Q4 24
-40.4%
8.5%
Q3 24
77.3%
6.9%
Q2 24
58.8%
-1.9%
Q1 24
78.1%
-1.4%
Capex Intensity
CASH
CASH
NATR
NATR
Q4 25
2.4%
1.9%
Q3 25
1.8%
1.3%
Q2 25
1.4%
1.2%
Q1 25
1.3%
1.0%
Q4 24
1.1%
1.9%
Q3 24
2.4%
1.5%
Q2 24
1.2%
3.0%
Q1 24
0.7%
3.3%
Cash Conversion
CASH
CASH
NATR
NATR
Q4 25
3.08×
2.41×
Q3 25
7.83×
3.46×
Q2 25
0.72×
0.81×
Q1 25
2.51×
0.55×
Q4 24
-2.39×
Q3 24
4.27×
2.21×
Q2 24
2.52×
0.97×
Q1 24
2.90×
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

NATR
NATR

Other$68.1M55%
General Health Products$20.2M16%
Digestive Products$13.8M11%
Cardiovascular Products$12.1M10%
Personal Care Products$4.4M4%
Immunity Products$3.1M3%
Weight Management Products$2.1M2%

Related Comparisons